p53 Protein immunoexpression in esophageal squamous cell carcinoma and adjacent epithelium

Journal of Surgical Oncology

Volumn 65, Issue 1, 1997, Pages 3-9

  Chaves, Paula ^a   Pereira, António Dias ^a   Pinto, António ^a   Oliveira, António Gouveia ^a   Queimado, Lurdes ^a   Gloria, Luísa ^a   Cardoso, Paula ^a   Mira, Francisco Costa ^a   Soares, Jorge ^a,b  

^a Lisbon Cancer Center   (Portugal)

^b INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

dysplasia; esophageal neoplasms; p53; prognosis; squamous cell carcinoma

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; EPITHELIUM; ESOPHAGEAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030971662     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199705)65:1<3::AID-JSO2>3.0.CO;2-C     Document Type: Article

References (48)

1. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-6311.
2. Rodrigues NR, Rowan A, Smith MEF, Kerr IB, Bodmer WF, Ganon JV, Lane DP: p53 mutations in colo-rectal cancer. Proc Natl Acad Sci 1990;87:7555-7559.
3. Brachman DG, Graves D, Vokes E, Becket M, Haraf D, Montag A, et al: Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res 1992;52:4832-4836.
4. Spruck CH, Tsai YC, Huang DP, Yang AS, Rideout WM, Gonzalez-Zulueta M, et al.: Absence of p53 gene mutations in primary nasopharyngeal carcinomas. Cancer Res 1992;52:4787-4790.
5. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992;358:80-83.
6. Barnes DM, Hanby AM, Gillet CE, Mohammed S, Hodgson S, Bobrow LG, et al.: Abnormal expression of wild-type p53 in normal cells of a cancer family patient. Lancet 1992;340:259-263.
7. Batsakis JG and El-Naggar AK. p53: Fifteen years after discovery. Adv Anat Pathol 1995;2:71-88.
8. Suzuki H, Takahashi T, Kuroishi T, Suyama M, Ariyoshi Y, Takahashi T, Ueda R: p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res 1992;52:734-736.
9. Davidoff AM, Herndon II JE, Glover NS, Kerns BJ, Pence JC, Iglehart JD, Marks JR: Relation between p53 overexpression and established prognostic factors in breast cancer. Surgery 1991;110: 259-264.
10. Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH, Smith HS: Accumulation of p53 tumour suppressor gene protein: An independent marker of prognosis in breast cancer. J Natl Cancer Inst 1992;84:845-854.
11. Thompson AM, Anderson TJ, Condie A, Prosser J, Chetty U, Carter DC, Evans HJ, Steel CM: p53 allele losses mutations and expression in breast cancer and their relationship to clinicopathological parameters. Int J Cancer 1992;50:528-532.
12. Effert PJ, Neubauer A, Walther PJ, Liv ET: Alteration of the p53 gene are associated with the progression of a human prostate carcinoma. J Urol 1992;147:3-8.
13. Sidransky D, Mikkelsen T: Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 1992;355: 6363-6365.
14. Field JK, Pavelic ZP, Spandilos DA, Strambook PJ, Jones AS, Gluckman JL: The role of the p53 tumour suppressor gene in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1993;119:1118-1122.
15. Frank JL, Bur ME, Garb JL, Kay S, Ware JL, Sismanis A, Neifeld JP: p53 tumour supressor oncogene expression in squamous cell carcinoma of the hipopharynx. Cancer 1994;73:181-186.
16. Sarbia M, Forschen R, Borchard F, Horstmann O, Willers R, Gabbert HE: p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer 1994;74:2218-2223.
17. Nadal A, Campo E, Pinto J, Mallofré C, Palacín A, Arias C, Traserra J, Cardesa A: p53 expression in normal, dysplastic and neoplastic laryngeal epithelium: Absence of a correlation with prognostic factors. J Pathol 1995;175:181-188.
18. Wang LD, Hong JY, Qiu SL, Yang CS: Immunohistochemical studies on p53 protein in human esophageal cancer and precancerous lesions. Proc Annu Meet Am Assoc Cancer Res 1992;33:A2295.
19. Volant A, Nousbaum JB, Giroux MA, Roué-Quintin I, Metges JP, Férec C, Gouérou H, Robaszkiewicz M: p53 protein accumulation in esophageal squamous cell carcinomas and precancerous lesions. J Clin Pathol 1995;48:531-534.
20. Parenti AR, Rugge M, Frizzera E, Ruol A, Noventa F, Ancona E, Ninfo V: p53 overexpression in the multistep process of esophageal carcinogenesis. Am J Surg Pathol 1995;12:1418-1422.
21. Bosari S, Roncalli M, Viale G, Bossi P, Coggi G: p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix. J Pathol 1993;169:425-430.
22. Watanabe H, Jass JR, Sobin LH: "Histological Typing of Esophageal and Gastric Tumours (WHO), 2nd, ed. New York: Springer-Verlag, 1990.
23. Beahrs OH: "Manual for Staging of Cancer," ed. 4. Philadelphia: JB Lippincott, 1992.
24. Cattoretti G, Becker M, Key G, Duchrow M, Schluter C, Galle J, Gerdes J: Monoclonal antibodies against recombinant parts of Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-363.
25. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathologic material using flow cytometry. J Histochem Cytochem 1983;31:1333-1335.
26. Dean P, Jett J: Mathematical analysis of DNA distributions derived from flow micro-fluorimetry. Cell Biology 1974;60:523.
27. Marquardt DW: An algorithm for least-squares estimation of nonlinear parameters. Soc Ind Appl Math 1963;11:431-441.
28. Flejou JF, Muzeau F, Potet F, Fekete F, Henin D: Overexpression of the p53 tumour supressor gene product in esophageal and gastric carcinomas. Pathol Res Pract 1994;190:1141-1148.
29. Vogelstein B, Kinzler KW: p53 function and dysfunction. Cell 1992;70:523-526.
30. Brash DE, Rudolph JA, Lin A, McKenna G, Baden HP, Halpern AJ, Ponten JA: A role for sunlight in skin cancer: UV-induced p53 mutation in squamous cell carcinoma. Proc Natl Acad Sci USA 1991;88:10124-10128.
31. Campbell C, Quinn AG, Angus B, Farr PM, Rees JL: Wavelength specific patterns of p53 induction in human skin following exposure to UV radiation. Cancer Res 1993;53:2697-2699.
32. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC: Mutational hot-spot in the p53 gene in human hepatocellular carcinomas. Nature 1991;350:427-428.
33. Bressac B, Kew M, Wands J, Ozturk M: Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991;350:429-431.
34. Hollstein M, Sidransky D, Vogelstein B, Harris C: p53 mutations in human cancers. Science 1991;253:49-53.
35. Tanaka S, Toh Y, Adachi E, Matsumata T, Mori R, Sugimachi K: Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res 1993;53:2884-2887.
36. Villuendas R, Piris MA, Orradre JL, Mollejo M, Algara P, Sanchez L, Martinez JC, Martinez P: p53 protein expression in lymphomas and reactive lymphoid tissue. J Pathol 1992;166:235-241.
37. Fukunaga M, Monden T, Nakanishi H, Ohue M, Fukuda K, Tomitu N, Shimano T, Mori T. Am J Clin Pathol 1994;101:177-180.
38. Bell SM, Scott N, Cross D, Sagar P, Lewis FA, Blair GE, Taylor GR, Dixon MF, Quirke P: Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology 1993;104:57-64.
39. Sasano H, Miyazaki S, Gooukon Y, Nishihira T, Sawai T, Nagura H: Expression of p53 in human esophageal carcinoma: an immunohistochemical study with correlation to proliferating cell nuclear antigen expression. Hum Pathol 1992;23:1238-1243.
40. Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirke P: p53 in colorectal cancer: Clinicopathological correlation and prognostic significance. Br J Cancer 1991;63:317-319.
41. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-1136.
42. Mansur CP, Marcus B, Dalai S, Androphy EJ: The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain. Oncogene 1995;10:457-465.
43. Wang LD, Hong JY, Qiu SL, Gao H, Yang CS: Accumulation of p53 protein in human esophageal precancerous lesions: A possible early marker for carcinogenesis. Cancer Res 1993;53:1783-1787.
44. Bartek J, Bartkova J, Vojtesek B, et al.: Patterns of expression of the tumour supressor gene in human breast tissues and tumours in situ and in vitro. Int J Cancer 1990;46:839-844.
45. Campo E, del la Calle-Martin O, Miquel R, et al.: Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas. Cancer Res 1991;52:4436-4442.
46. Joypaul BV, Newman EL, Hopwood D, et al.: Expression of p53 protein in normal, dysplastic, and malignant gastric mucosa: an immunohistochemical study. J Pathol 1993;170:279-283.
47. Dobashi Y, Sakamoto A, Sugimura H, et al.: Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. Am J Surg Pathol 1993;17:375-381.
48. Fugimoto K, Yamada Y, Okajima E, et al.: Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res 1992;52:1393-1398.